Stephen Warren, Icon of Fragile X Research, Dies at 67

He famously identified the genetic mutation that causes the condition in 1991.

Written byLisa Winter
| 2 min read
Man with glasses wearing yellow long sleeve shirt sits at a desk, surrounded by stacks of paper

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

ABOVE: Warren sitting at his desk in 1999
BOBBY HAWKINS PHOTOGRAPHY

Geneticist Stephen Warren died at his home in Atlanta after a brief illness on June 6. Warren was best known for his work identifying the mutations responsible for fragile X syndrome, a genetic disorder linked to intellectual disabilities and certain mood disorders. He was 67.

Warren was born an only child in what was then known as East Detroit in 1953. He told PNAS in a 2015 profile that it was his father, a dentist, who sparked his love of science. In 1972, he began his undergraduate studies at Michigan State University, initially studying zoology. According to a profile by Emory University, Warren’s introduction to genetics came when he started a part-time job running diagnostic tests. He ended up taking every graduate-level genetics course the school offered, and during the summers, he returned to Detroit to work with geneticists at ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Lisa joined The Scientist in 2017. As social media editor, some of her duties include creating content, managing interactions, and developing strategies for the brand’s social media presence. She also contributes to the News & Opinion section of the website. Lisa holds a degree in Biological Sciences with a concentration in genetics, cell, and developmental biology from Arizona State University and has worked in science communication since 2012.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies